Loading organizations...
§ Private Profile · Haimen, Guangdong, China
Developer of biopharmaceutical technologies for protein and vaccine product
Thousand Oaks Biopharmaceuticals has raised $170.6M across 3 funding rounds.
Thousand Oaks Biopharmaceuticals has raised $170.6M in total across 3 funding rounds.
Thousand Oaks Biopharmaceuticals has raised $170.6M in total across 3 funding rounds.
Thousand Oaks Biopharmaceuticals's investors include CDH Investments, CICC Capital, Fosun, Honghui Capital, Jinshi Capital, CITIC Securities, Liefeng Qu, Blue Bay Capital, Ji Lin Ao Dong, Qianrong Holdings, Tenyall & Sumin.
Thousand Oaks Biopharmaceuticals has raised $170.6M across 3 funding rounds. Most recently, it raised $61.4M Series C in March 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 10, 2021 | $61.4M Series C | — | CDH Investments, CICC Capital, Fosun 复星, Honghui Capital, Jinshi Capital | Announced |
| Jul 24, 2020 | $64.2M Series B | CICC Capital, CITIC Securities | — | Announced |
| Jan 3, 2019 | $45M Series A | Liefeng QU | Blue BAY Capital, JI LIN AO Dong, Qianrong Holdings, Tenyall & Sumin | Announced |